Let’s shout about the complexity of nursingNICE publishes draft guidance on ovarian cancer drug
Draft guidance on the use of bevacizumab as a treatment for women with advanced ovarian cancer has been published by the National Institute for Health and Clinical Excellence (NICE).
Continue reading - simply register below
It only takes two minutes to do and you'll immediately have access to our news and opinion articles and you'll be able to sign up for our newsletters.
Already registered?
To check that you are registered please enter your email address below
Not registered?
Registration is free and takes just two minutes. After you register, you'll get access to our news and opinion stories and you'll be able to sign up to our newsletters.
